168 related articles for article (PubMed ID: 19344999)
1. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.
Hypes MK; Pirisi L; Creek KE
Cancer Lett; 2009 Sep; 282(2):177-86. PubMed ID: 19344999
[TBL] [Abstract][Full Text] [Related]
2. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression.
Mi Y; Borger DR; Fernandes PR; Pirisi L; Creek KE
Virology; 2000 May; 270(2):408-16. PubMed ID: 10793000
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta.
Borger DR; Mi Y; Geslani G; Zyzak LL; Batova A; Engin TS; Pirisi L; Creek KE
Virology; 2000 May; 270(2):397-407. PubMed ID: 10792999
[TBL] [Abstract][Full Text] [Related]
4. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
Baldwin A; Pirisi L; Creek KE
J Virol; 2004 Apr; 78(8):3953-64. PubMed ID: 15047811
[TBL] [Abstract][Full Text] [Related]
5. Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes.
Creek KE; Geslani G; Batova A; Pirisi L
Adv Exp Med Biol; 1995; 375():117-35. PubMed ID: 7645423
[TBL] [Abstract][Full Text] [Related]
6. Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes.
Altomare D; Velidandla R; Pirisi L; Creek KE
BMC Cancer; 2013 Sep; 13():424. PubMed ID: 24047375
[TBL] [Abstract][Full Text] [Related]
7. HPV16-transformed human keratinocytes depend on SIX1 expression for proliferation and HPV E6/E7 gene expression.
Hosseinipour M; Wan F; Altomare D; Creek KE; Pirisi L
Virology; 2019 Nov; 537():20-30. PubMed ID: 31425971
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
[TBL] [Abstract][Full Text] [Related]
9. 5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.
Ammanamanchi S; Brattain MG
J Biol Chem; 2001 Aug; 276(35):32854-9. PubMed ID: 11443124
[TBL] [Abstract][Full Text] [Related]
10. TGF-β regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes.
Kowli S; Velidandla R; Creek KE; Pirisi L
Virology; 2013 Dec; 447(1-2):63-73. PubMed ID: 24210100
[TBL] [Abstract][Full Text] [Related]
11. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid suppresses human papillomavirus type 16 (HPV16)-mediated transformation of human keratinocytes and inhibits the expression of the HPV16 oncogenes.
Creek KE; Jenkins GR; Khan MA; Batova A; Hodam JR; Tolleson WH; Pirisi L
Adv Exp Med Biol; 1994; 354():19-35. PubMed ID: 8067286
[TBL] [Abstract][Full Text] [Related]
13. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
Ammanamanchi S; Brattain MG
J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
[TBL] [Abstract][Full Text] [Related]
14. Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer.
Chen Y; Pirisi L; Creek KE
Virology; 2013 Sep; 444(1-2):100-8. PubMed ID: 23809940
[TBL] [Abstract][Full Text] [Related]
15. Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes.
Xu H; Zhang Y; Altomare D; Peña MM; Wan F; Pirisi L; Creek KE
Carcinogenesis; 2014 Jun; 35(6):1379-88. PubMed ID: 24574515
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons.
Khan MA; Tolleson WH; Gangemi JD; Pirisi L
J Virol; 1993 Jun; 67(6):3396-403. PubMed ID: 8388505
[TBL] [Abstract][Full Text] [Related]
17. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG
Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155
[TBL] [Abstract][Full Text] [Related]
18. Sp3 is a transcriptional repressor of transforming growth factor-beta receptors.
Ammanamanchi S; Brattain MG
J Biol Chem; 2001 Feb; 276(5):3348-52. PubMed ID: 11027677
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes.
Khan MA; Jenkins GR; Tolleson WH; Creek KE; Pirisi L
Cancer Res; 1993 Feb; 53(4):905-9. PubMed ID: 8381332
[TBL] [Abstract][Full Text] [Related]
20. Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor.
Ji C; Casinghino S; McCarthy TL; Centrella M
J Biol Chem; 1997 Aug; 272(34):21260-7. PubMed ID: 9261136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
